Other
Castleman Disease Collaborative Network
Total Trials
3
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
Failure Rate
33.3%
1 terminated/withdrawn out of 3 trials
Success Rate
50.0%
-36.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed trials have results
Key Signals
1 recruiting
Enrollment Performance
Analytics
No phase data available
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT02817997Recruiting
International Registry for Patients With Castleman Disease
Role: collaborator
NCT02853968Completed
Unlock the Cell: Castleman's Disease Flow Cytometry Study
Role: collaborator
NCT02871050Withdrawn
Castleman Disease Collaborative Network Biobank
Role: lead
All 3 trials loaded